Login / Signup
Lika Osugui
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 5
Top Topics
Stem Cells
Inflammatory Response
Lipopolysaccharide Induced
Climate Change
Top Venues
Clinical and translational medicine
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Gerardo-Javier Martí-Chillón
,
Sandra Muntión
,
Silvia Preciado
,
Lika Osugui
,
Almudena Navarro-Bailón
,
Javier González-Robledo
,
Víctor Sagredo
,
Juan F Blanco
,
Fermin M Sanchez-Guijo
Therapeutic potential of mesenchymal stromal/stem cells in critical-care patients with systemic inflammatory response syndrome.
Clinical and translational medicine
13 (1) (2023)
Gerardo-Javier Martí-Chillón
,
Sandra Muntión
,
Silvia Preciado
,
Lika Osugui
,
Almudena Navarro-Bailón
,
Javier González-Robledo
,
Víctor Sagredo
,
Juan F Blanco
,
Fermin M Sanchez-Guijo
Therapeutic potential of mesenchymal stromal/stem cells in critical-care patients with systemic inflammatory response syndrome.
Clinical and translational medicine
13 (1) (2023)
Gerardo-Javier Martí-Chillón
,
Sandra Muntión
,
Silvia Preciado
,
Lika Osugui
,
Almudena Navarro-Bailón
,
Javier González-Robledo
,
Víctor Sagredo
,
Juan F Blanco
,
Fermin M Sanchez-Guijo
Therapeutic potential of mesenchymal stromal/stem cells in critical-care patients with systemic inflammatory response syndrome.
Clinical and translational medicine
13 (1) (2023)
Gerardo-Javier Martí-Chillón
,
Sandra Muntión
,
Silvia Preciado
,
Lika Osugui
,
Almudena Navarro-Bailón
,
Javier González-Robledo
,
Víctor Sagredo
,
Juan F Blanco
,
Fermin M Sanchez-Guijo
Therapeutic potential of mesenchymal stromal/stem cells in critical-care patients with systemic inflammatory response syndrome.
Clinical and translational medicine
13 (1) (2023)
Gerardo-Javier Martí-Chillón
,
Sandra Muntión
,
Silvia Preciado
,
Lika Osugui
,
Almudena Navarro-Bailón
,
Javier González-Robledo
,
Víctor Sagredo
,
Juan F Blanco
,
Fermin M Sanchez-Guijo
Therapeutic potential of mesenchymal stromal/stem cells in critical-care patients with systemic inflammatory response syndrome.
Clinical and translational medicine
13 (1) (2023)